SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Google Facts Zone
GOOG 291.55+0.3%3:57 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Lizzie Tudor who wrote (3153)2/20/2009 4:24:17 PM
From: Patsy Collins   of 3618
 
Roughly 40%, 37.5% to be exact of JNJ is pharma.
You could say that 74.3% of JNJ is healthcare related. so any serious govt jawboning may hurt JNJ with only its consumer goods serving as its alpha portfolio.

To be fair, the pharmas do not make anywhere near 99% margins.
As an investor, I dearly wish that were true.
There will be talks of healthcare reforms, but serious talks and draconian moves are not likely anytime soon.

Options on BRK does exist, it's call BRK class B shares.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News